PeterStubbsPT Profile Banner
Peter Stubbs Profile
Peter Stubbs

@PeterStubbsPT

Followers
358
Following
680
Media
16
Statuses
1K

Husband | Father | Teacher | Researcher - #Neurorehabilitation, PhysDB-FCP database, #VR, #MetaResearch, #EBM | #Karaoke songster | Views are my own

Sydney, New South Wales
Joined December 2017
Don't wanna be here? Send us removal request.
@IHME_UW
Institute for Health Metrics and Evaluation (IHME)
29 days
We are excited to announce the official release of the Global Burden of Disease 2023 study! GBD 2023 data visualization tools, videos, infographics, and resources are now available: https://t.co/rsZFg7Vhln
healthdata.org
We are pleased to share that results from the GBD 2023 study. Learn more about the many resources available for navigating the study data and key findings.
1
16
25
@IHME_UW
Institute for Health Metrics and Evaluation (IHME)
29 days
Three GBD 2023 capstones have just been published in @TheLancet • Global demographic analysis: https://t.co/4FD12Yx67C • Global causes of death: https://t.co/y3LAQ5lZ2g • Global burden of diseases, injuries, and risk factors: https://t.co/EZA60LRjRk
2
22
27
@UTSPhysio
Physio UTS
4 months
🎉 It’s back! #UTSPhysio Research Showcase returns on Friday 31 Oct 🧠💡 Celebrate our standout Master of Physiotherapy students research presentations + hear from leading guest speakers. 📅 Save the date & register now! 👉 https://t.co/lx5OqJ7VcZ
0
3
2
@AndyMetOrtho
Andy Metcalfe
5 months
Great paper for the outcomes geeks among us (me included..) Should we move from SWE rather than anchor based MCIDs? I’m sold…
@TobyOSmith
Toby Smith
5 months
One to prioritise reading for lots of reasons - smallest worthwhile effect of discectomy vs. non-surgical treatments for people with sciatica. Really valuable analysis from @giovanni_ef @ProfManuelaF & co. Well done team 👏
1
1
6
@GuyattGH
Gordon H. Guyatt
5 months
Interested in the evidence to decide whether to use #Likert or visual analogue scales (#VAS) for your health status measurement instrument? #Responsiveness to change similar, Likert more convenient and easier to interpret. https://t.co/kcmqKwKVQe
pubmed.ncbi.nlm.nih.gov
Many controlled trials rely on subjective measures of symptoms or quality of life as primary outcomes. The relative merits of different response options for these measures is an important, but...
0
7
10
@lakens
Daniël Lakens
5 months
The journal of sport sciences recently made a sample size justification section mandatory. More and more journals are implementing this, as it is a central part of a study! Learn how to create a state of the art sample size justification from my paper:
online.ucpress.edu
An important step when designing an empirical study is to justify the sample size that will be collected. The key aim of a sample size justification for such studies is to explain how the collected...
1
25
140
@GuyattGH
Gordon H. Guyatt
6 months
Ground-breaking, still highly relevant paper established that specific health status measurement #instruments are better at detecting treatment effects – that is, more responsive – than are generic instruments. https://t.co/RUQdZYjitG
pubmed.ncbi.nlm.nih.gov
We assessed the relative responsiveness of generic and specific quality of life instruments in 43 randomized controlled trials that compared head-to-head 31 generic and 84 specific instruments. Using...
0
8
12
@JOSPT
JOSPT Community
6 months
Do you know your Odds Ratio from your Risk Ratio 🤔 If not, don't fear, Dr Kamper is back with the popular #EvidenceInPractice series to explain all ... Read more ➡️ https://t.co/1GoxRdaIF6 #yourJOSPT
0
17
64
@GuyattGH
Gordon H. Guyatt
6 months
Just published #JAMA Intern Med demonstrating that many #SystematicReviews of #RCTs include retracted studies and their inclusion can substantially influence results. Search for #retractions should now be standard in systematic reviews. #EBM #Medicine https://t.co/FOZryFC9d9
pubmed.ncbi.nlm.nih.gov
This study found that retracted studies have been included in systematic reviews and meta-analyses, with retractions occurring mainly after the publication of the systematic review. The inclusion of...
2
32
96
@AsafKlaf
Asaf (Klaf) Weisman
6 months
Our new paper is published 💥 The primary argument is that surgery is not, and cannot be, a "true" placebo in the classical sense. This argument leads to the hypothesis that the improvement in pain observed after sham surgeries is mediated by the potent general and local
7
13
59
@GuyattGH
Gordon H. Guyatt
7 months
As previous post, a 2 minute video in which I describe the second of 7 Core GRADE articles appearing in the BMJ. This one, published today, shows to choose the target of the certainty rating and address imprecision in systematic reviews and guidelines. https://t.co/oIOM98qrlr
linkedin.com
As previous post, a 2 minute video in which I describe the second of 7 Core GRADE articles appearing in the BMJ. This one, published today, shows to choose the target of the certainty rating and...
0
10
19
@GSCollins
Gary Collins
7 months
NEW PAPER: Updated SPIRIT-2025 for reporting protocols of randomised trials is now available in the @bmj_latest @JAMA_current @TheLancet @NatureMedicine @PLOSMedicine —> https://t.co/EDkjxGCxAq #openscience #transparency #medX #statsX #epiX
1
63
130
@MarionKCampbell
Marion Campbell
7 months
A major update to the CONSORT reporting guidance for clinical trials was published last week. 📌 CONSORT 2025 replaces all previous versions and should be used from now on. So what’s new and what’s different? 1/7 #MethodologyMonday #116 (COI - I am a co-author)
1
50
102
@GuyattGH
Gordon H. Guyatt
7 months
Big news for #EBM! Just out in #BMJ, ROBUST-RCT, pristinely developed, innovative, simple, user-friendly instrument for risk of bias assessment in #RCTs far superior to anything before, will become standard outside of Cochrane and in #Cochrane if they let folks use it.
bmj.com
Recent innovations in evidence based medicine methods, in particular instruments assessing risk of bias in randomised trials, have focused on methodological rigour at the expense of simplicity and...
9
61
161
@stevekamper1
Steve Kamper
7 months
It's been a while but another Evidence in Practice article is out: an explainer on odds and risk, which are used to measure dichotomous outcomes (recovered/unrecovered, injured/not injured etc) Direct message or email if you can't access and want a pdf https://t.co/cuuNvmjoNn
5
21
58
@stevekamper1
Steve Kamper
8 months
Not sure who's still here, but anyway! We collected all the placebo controlled trials for non-surgical Rx on back pain together in a systematic review. It was pretty epic, and pretty sobering results-wise. Hope you like it. https://t.co/hiQO8q3lNe
12
42
116
@Rafael_Z_Pinto
Rafael Zambelli
8 months
Our trial shows an e-learning program can improve physios’ beliefs about low back pain! - summary: https://t.co/5ClygHHq6I - full paper: https://t.co/N1Yj1eUCrV
0
5
11
@GuyattGH
Gordon H. Guyatt
8 months
Just published #BMJ paper: strong against all interventional procedures for spine pain (joint radio frequency ablation; epidural injections; intramuscular injections, etc.) useless & harmful but lucrative. How to stop clear: stop paying. But can it happen?
bmj.com
Clinical question What is the comparative effectiveness and safety of commonly used interventional procedures (such as spinal injections and ablation procedures) for chronic axial and radicular spine...
1
15
41
@bmj_latest
The BMJ
9 months
"Data show that black doctors are more than twice as likely to be referred by their employers compared with their white colleagues, with those trained overseas at even greater risk." Work must continue to improve things, Abi Rimmer hears https://t.co/5We7n7rxMC
bmj.com
A referral is statistically more likely, so work must continue to improve things, Abi Rimmer hears Udvitha Nandasoma, MDU head of advisory services, says, “The General Medical Council’s State of...
0
10
17